[Mindray Announces Third Quarter 2011 Financial Results Shenzhen, China – November 7, 2011 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2011. Highlights for Third Quarter 2011 - Net revenues were $218.4 million, up 29.8% over the] [Mindray Announces Up to $100 Million Share Repurchase Program Shenzhen, China – November 7, 2011 – Mindray Medical International Limited (“Mindray” or “Company”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The share repurchase program is authorized to be in effect through December]

[Mindray Announces Third Quarter 2011 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China November7, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2011. Highlights for Third Quarter 2011 -] [STYLE="font-family:Times New Roman" SIZE="2"> Mindray Announces Up to $100 Million Share Repurchase Program Shenzhen, China November7, 2011 Mindray Medical International Limited (Mindray ormpany, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The share repurchase program is authorized to]

[Mindray Announces Third Quarter 2011 Financial Results Shenzhen, China November7, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2011. Highlights for Third Quarter 2011 - Net revenues were $218.4 million, up 29.8% over] [Mindray Announces Up to $100 Million Share Repurchase Program Shenzhen, China November7, 2011 Mindray Medical International Limited (Mindray ormpany, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The share repurchase program is authorized to be in effect through]

[Mindray Announces Second Quarter 2011 Financial Results Shenzhen, China – August 8, 2011 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2011. Highlights for Second Quarter 2011 • Net revenues were $217.3 million, an increase of 21.2%]